With critical limb ischemia (CLI) being a multi-factorial disease. it is becoming evident that gene therapy with a multiple bio-functional growth factor could achieve better therapeutic outcomes. Cytochrome P450 epoxygenase-2J2 (CYP2J2) and its catalytic products epoxyeicosatrienoic acids (EETs) exhibit pleiotropic biological activities. including pro-angiogenic. https://www.hindigyanvishv.com/super-save-Smart-Tv-Led-32-Hd-Panasonic-32fs500b-2-Hdmi-2-Usb-Wi-fi-Conversor-Digital-super-buy/